Caribou Biosciences, Inc.
CRBU
$1.99
$0.10815.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.51% | 3.01% | -2.85% | -246.77% | -27.70% |
| Total Depreciation and Amortization | 36.33% | 64.08% | 60.00% | -25.46% | 38.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,065.08% | -13.74% | -57.38% | 115.38% | -31.57% |
| Change in Net Operating Assets | -80.64% | -76.21% | -185.63% | 87.20% | -76.33% |
| Cash from Operations | 14.02% | 1.28% | -65.91% | -13.45% | -116.44% |
| Capital Expenditure | 81.35% | 28.04% | 77.25% | 85.84% | 12.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.32% | 106.62% | 156.29% | 142.67% | 72.15% |
| Cash from Investing | 13.38% | 115.11% | 150.61% | 138.73% | 91.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.45% | -96.25% | -- | -99.82% | -99.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.45% | -96.25% | 9,083.72% | -99.82% | -99.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.45% | 844.84% | 70.36% | -115.57% | -185.75% |